Item 1.01 Entry into a Material Definitive Agreement.

On September 1, 2022, United Health Products, Inc. (the "Company") entered into a common stock purchase agreement (the "CSPA") with White Lion Capital, LLC ("White Lion"). Pursuant to the CSPA, the Company has the right, but not the obligation, to require White Lion to purchase up to $10,000,000 of the Company's common stock, subject to certain limitations and conditions set forth in the CSPA. The Company is required to register the resale of the shares issuable to White Lion under the CSPA with the U.S. Securities and Exchange Commission, as a condition to requesting White Lion purchase shares.

The Company's right to sell shares to White Lion will commence on the effective date of the resale registration statement and extends for a period of three years. During this term, the Company may exercise its right to sell shares to White Lion, subject to limitations on the amount of shares that are permitted to be sold with each exercise. The purchase price to be paid by White Lion for such shares will equal the lower of: (i) 93% of the volume-weighted average price of the Company's common stock during a period of five consecutive trading days following the Company's exercise of its right to sell shares, and (ii) the closing price of the common stock on the day the Company exercises its right to sell shares, subject to a minimum price of $0.30 per share.

In consideration for White Lion's commitment to purchase shares under the CSPA when requested, the Company will issue 757,576 shares to White Lion.

The Company will have the right to terminate the CSPA at any time, at no cost or penalty, upon ten trading days' prior written notice. Additionally, White Lion will have the right to terminate the CSPA in accordance with its terms for certain breaches of the CSPA by the Company, a Company bankruptcy filing, or the Company's CEO, Principal Financial Officer or Director of Operations terminating their respective employment with the Company.

The foregoing description of the CSPA is not complete and is subject to, and qualified in its entirety by, the full text of the CSPA, a copy of which is attached to this Report as Exhibit 10.1, the terms of which are incorporated herein by reference.




Item 8.01. Other Events.

On September 6, 2022, the Company issued a press release announcing the CSPA with White Lion.

A copy of the press release is attached as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.





(d) Exhibits



Exhibit
Number     Description

  10.1       Common Stock Purchase Agreement, dated September 1, 2022
  99.1       Press release, dated September 6, 2022
104        Cover Page Interactive Data File (embedded within the Inline XBRL
           Document)





2

© Edgar Online, source Glimpses